1445P A randomized phase III trial on Pembrolizumab Alone versUs pembrolizumab-chemotherapy in first LInE NSCLC (PAULIEN), results of the interim analysis
Autor: | Houda, I., Ulas, E.B., Hashemi, S.M.S., Becker, A., Daniels, H.M.A., Tarasevych, S., Looysen, E., Kunst, P., Moons-Pasic, A., Thönissen, N., van Haarst, J.M.W., van Tilburg, P., van der Maat, B., Barlo, N., Disselhorst, M., van Diepen, V., Tiemessen, M., van Laren, M., Veltman, J., Bahce, I. |
---|---|
Zdroj: | In Annals of Oncology October 2023 34 Supplement 2:S821-S822 |
Databáze: | ScienceDirect |
Externí odkaz: |